Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 11 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QAK0
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 13 |
GO:0006457 | protein folding | 2 | 6 |
GO:0006807 | nitrogen compound metabolic process | 2 | 13 |
GO:0008152 | metabolic process | 1 | 13 |
GO:0009987 | cellular process | 1 | 6 |
GO:0018193 | peptidyl-amino acid modification | 5 | 13 |
GO:0018208 | peptidyl-proline modification | 6 | 13 |
GO:0019538 | protein metabolic process | 3 | 13 |
GO:0036211 | protein modification process | 4 | 13 |
GO:0043170 | macromolecule metabolic process | 3 | 13 |
GO:0043412 | macromolecule modification | 4 | 13 |
GO:0044238 | primary metabolic process | 2 | 13 |
GO:0071704 | organic substance metabolic process | 2 | 13 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 13 |
GO:0003824 | catalytic activity | 1 | 13 |
GO:0005488 | binding | 1 | 2 |
GO:0016018 | cyclosporin A binding | 4 | 2 |
GO:0016853 | isomerase activity | 2 | 13 |
GO:0016859 | cis-trans isomerase activity | 3 | 13 |
GO:0033218 | amide binding | 2 | 2 |
GO:0042277 | peptide binding | 3 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 226 | 228 | PF00675 | 0.550 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.648 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.446 |
DEG_SPOP_SBC_1 | 9 | 13 | PF00917 | 0.403 |
DOC_CYCLIN_yCln2_LP_2 | 4 | 10 | PF00134 | 0.382 |
DOC_PP1_RVXF_1 | 193 | 200 | PF00149 | 0.281 |
DOC_PP2B_LxvP_1 | 44 | 47 | PF13499 | 0.468 |
DOC_PP4_FxxP_1 | 6 | 9 | PF00568 | 0.393 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.373 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.379 |
DOC_USP7_UBL2_3 | 112 | 116 | PF12436 | 0.260 |
DOC_USP7_UBL2_3 | 50 | 54 | PF12436 | 0.572 |
DOC_WW_Pin1_4 | 90 | 95 | PF00397 | 0.261 |
LIG_14-3-3_CanoR_1 | 168 | 174 | PF00244 | 0.342 |
LIG_BRCT_BRCA1_1 | 169 | 173 | PF00533 | 0.267 |
LIG_BRCT_BRCA1_1 | 175 | 179 | PF00533 | 0.263 |
LIG_Clathr_ClatBox_1 | 71 | 75 | PF01394 | 0.315 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.444 |
LIG_EVH1_1 | 6 | 10 | PF00568 | 0.353 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.367 |
LIG_FHA_2 | 169 | 175 | PF00498 | 0.347 |
LIG_LIR_Apic_2 | 5 | 9 | PF02991 | 0.385 |
LIG_LIR_Gen_1 | 12 | 21 | PF02991 | 0.424 |
LIG_LIR_Gen_1 | 176 | 187 | PF02991 | 0.367 |
LIG_LIR_Gen_1 | 22 | 29 | PF02991 | 0.447 |
LIG_LIR_Gen_1 | 236 | 242 | PF02991 | 0.449 |
LIG_LIR_LC3C_4 | 33 | 38 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 12 | 18 | PF02991 | 0.453 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.308 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 78 | 84 | PF02991 | 0.296 |
LIG_MLH1_MIPbox_1 | 175 | 179 | PF16413 | 0.265 |
LIG_Pex14_2 | 15 | 19 | PF04695 | 0.431 |
LIG_PTB_Apo_2 | 119 | 126 | PF02174 | 0.311 |
LIG_SH2_CRK | 161 | 165 | PF00017 | 0.261 |
LIG_SH2_CRK | 81 | 85 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 232 | 235 | PF00017 | 0.402 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.461 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.365 |
LIG_SUMO_SIM_par_1 | 35 | 41 | PF11976 | 0.443 |
LIG_SUMO_SIM_par_1 | 82 | 87 | PF11976 | 0.261 |
LIG_TRFH_1 | 6 | 10 | PF08558 | 0.353 |
LIG_UBA3_1 | 71 | 76 | PF00899 | 0.334 |
LIG_WW_3 | 46 | 50 | PF00397 | 0.538 |
MOD_CDK_SPK_2 | 90 | 95 | PF00069 | 0.261 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.141 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.127 |
MOD_CK1_1 | 169 | 175 | PF00069 | 0.373 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.494 |
MOD_CK1_1 | 90 | 96 | PF00069 | 0.437 |
MOD_GlcNHglycan | 218 | 222 | PF01048 | 0.384 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.469 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.576 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.301 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.407 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.377 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.321 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.249 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.443 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.273 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.281 |
MOD_NEK2_2 | 10 | 15 | PF00069 | 0.372 |
MOD_PIKK_1 | 173 | 179 | PF00454 | 0.301 |
MOD_PKA_2 | 123 | 129 | PF00069 | 0.296 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.299 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.617 |
MOD_Plk_1 | 235 | 241 | PF00069 | 0.339 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.456 |
MOD_ProDKin_1 | 90 | 96 | PF00069 | 0.261 |
TRG_DiLeu_BaEn_1 | 32 | 37 | PF01217 | 0.458 |
TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.261 |
TRG_ENDOCYTIC_2 | 239 | 242 | PF00928 | 0.569 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.469 |
TRG_ENDOCYTIC_2 | 81 | 84 | PF00928 | 0.389 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3D1 | Leptomonas seymouri | 68% | 100% |
A0A0N0P523 | Leptomonas seymouri | 32% | 88% |
A0A0S4J351 | Bodo saltans | 28% | 91% |
A0A1X0ND98 | Trypanosomatidae | 40% | 100% |
A0A3R7RE54 | Trypanosoma rangeli | 31% | 94% |
A0A3S7WXF4 | Leishmania donovani | 31% | 82% |
A0A3S7WYD9 | Leishmania donovani | 93% | 100% |
A4H4H8 | Leishmania braziliensis | 32% | 100% |
A4HCL8 | Leishmania braziliensis | 29% | 82% |
A4HDL1 | Leishmania braziliensis | 79% | 100% |
A4HLM4 | Leishmania braziliensis | 27% | 100% |
A4I042 | Leishmania infantum | 31% | 82% |
A4I0X0 | Leishmania infantum | 93% | 100% |
C9ZUX8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 80% |
C9ZWH7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AWX4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
P29117 | Rattus norvegicus | 31% | 100% |
P52011 | Caenorhabditis elegans | 30% | 100% |
Q38867 | Arabidopsis thaliana | 30% | 100% |
Q4G338 | Haemonchus contortus | 30% | 75% |
Q4Q424 | Leishmania major | 28% | 100% |
Q4QBH1 | Leishmania major | 31% | 82% |
Q99KR7 | Mus musculus | 30% | 100% |
V5B2A0 | Trypanosoma cruzi | 33% | 94% |
V5D532 | Trypanosoma cruzi | 28% | 100% |